Table 5.
Brachytherapy only +/−NADT distribution of participant responses to EPIC Hormone/Vitality HRQOL items at baseline, 6, 12, and 24 months.
| NADT | No NADT | P value* | |||||
|---|---|---|---|---|---|---|---|
| How big a problem during the last 4 weeks, if any, has each of the following been for you? | Moderate problem + Big problem | No Problem + Very small problem + Small problem | n | Moderate problem + Big problem | No Problem + Very small problem + Small problem | n | |
| Hot flashes[1] | 0.1014 | ||||||
| Baseline: | 0% | 100% | 14 | 0.7% | 99.3% | 270 | |
| 6 months: | 15.4% | 84.6% | 13 | 2.4% | 97.6% | 253 | |
| 12 months: | 0% | 100% | 12 | 0.8% | 99.2% | 250 | |
| 24 months: | 8.3% | 91.7% | 12 | 1.3% | 98.7% | 233 | |
| Breast tenderness/enlargement[1] | 0.7551 | ||||||
| Baseline: | 0% | 100% | 14 | 0.7% | 99.3% | 270 | |
| 6 months: | 7.7% | 92.3% | 13 | 1.2% | 98.8% | 253 | |
| 12 months: | 0% | 100% | 12 | 0.8% | 99.2% | 250 | |
| 24 months: | 0% | 100% | 12 | 0.9% | 99.1% | 233 | |
| Feeling depressed[1] | 0.9208 | ||||||
| Baseline: | 0% | 100% | 14 | 4.1% | 95.9% | 271 | |
| 6 months: | 15.4% | 84.6% | 13 | 4.3% | 95.7% | 254 | |
| 12 months: | 16.7% | 83.3% | 12 | 3.6% | 96.4% | 249 | |
| 24 months: | 0% | 100% | 12 | 5.2% | 94.9% | 233 | |
| Lack of energy | 0.3000 | ||||||
| Baseline: | 7.1% | 92.9% | 14 | 6.7% | 93.3% | 270 | |
| 6 months: | 30.8% | 69.2% | 13 | 15.8% | 84.3% | 254 | |
| 12 months: | 8.3% | 91.7% | 12 | 14.4% | 85.6% | 250 | |
| 24 months: | 8.3% | 91.7% | 12 | 11.6% | 88.4% | 233 | |
| Change in body weight[1] | 0.0501 | ||||||
| Baseline: | 0% | 100% | 14 | 3.0% | 97.1% | 271 | |
| 6 months: | 30.8% | 69.2% | 13 | 5.9% | 94.1% | 254 | |
| 12 months: | 16.7% | 83.3% | 12 | 7.6% | 92.4% | 249 | |
| 24 months: | 8.3% | 91.7% | 12 | 6.0% | 94.0% | 233 | |
P value reflects a test of the interaction term between group and the time points in linear generalized estimating equations (GEE).
Cochran-Mantel-Haenszel test